Skip to main content
Clinical Trials/ACTRN12605000027617
ACTRN12605000027617
Recruiting
Not Applicable

A controlled trial of ovulation stimulation with intrauterine insemination versus in vitro ferilisation on clinical pregnancy rates in patient with idiopathic or mild male infertility

Melbourne IVF0 sites812 target enrollmentJuly 19, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Melbourne IVF
Enrollment
812
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 19, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Infertility of 12 months or longer duration2\) Primary or secondary infertility3\)New patient or patient returning after an interval of longer than 1 year4\) Female age 18\-42, male age 18\-80 years5\) Detailed male and female partner clinical evaluation, investigation of semen quality and objective evidence of ovulation and tubal patency

Exclusion Criteria

  • 1\) Coital disorders, including infrequent or mistimed coitus (\<1 per 3 days during mid cycle)2\) Tubal obstruction (one or both) or known ligation.3\) Male infertility requiring ICSI: average sperm concentration less than 2 million/mL, progressive motility less than 25%, or abnormal morphology greater than 85% in two or more semen test performed within the previous 12 month in RWH andrology lab, sperm autoimmunity (IBT IgG or IgA antibodies on \>50% of motile sperm together with blocked sperm mucus penetration4\) untreated ovulatory disorders5\)Ovarian endometrioma6\)Currently treated patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A controlled trial of ovulation stimulation with intrauterine insemination (IUI) versus in vitro fertilisation (IVF)
ISRCTN28780587The Royal Women's Hospital (Australia)600
Recruiting
Phase 3
Effect of triggering ovulation with HCG alone and dual triggering by HCG plus GnRh agonist on oocytes maturation and clinical pregnancy rate in POSEIDON group 4 in IVF cycles
IRCT20201121049457N2Mashhad University of Medical Sciences170
Not yet recruiting
Phase 1
A study to observe the effect of Pushpadhanva Rasa on rupture of ovum from ovaries.Health Condition 1: null- Female patients with primary or secondary infertility due to Anovulation.Health Condition 2: E288- Other ovarian dysfunction
CTRI/2018/10/016231Parul Institute of Ayurveda
Active, not recruiting
Not Applicable
Fertility preservation in breast cancer patients: oocytes or embryos vitrification.The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromatase, is administered during standard gonadotropins ovarian stimulation to maintain a low estradiol level during ovarian stimulation in patients with hormono-sensitive tumour.MedDRA version: 18.1Level: LLTClassification code 10006190Term: Breast cancer invasive NOSSystem Organ Class: 100000004864MedDRA version: 18.1Level: LLTClassification code 10016465Term: Fertility female decreasedSystem Organ Class: 100000004872MedDRA version: 18.1Level: LLTClassification code 10016463Term: Fertility decreased femaleSystem Organ Class: 100000004872Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2012-003412-31-BECUB - Hôpital Erasme
Recruiting
Phase 4
To compare if spontaneous ovulation is better than ovulation triggered by administering human chorionic gonadotropin to improve pegnancy rates in gonadotropin stimulated intrauterine insemination cycles.Health Condition 1: null- Infertile couples undergoing stimulated intrauterine insemination cycles
CTRI/2013/07/003795il392